Skip to content

Treatment protocol for adult acute lymphoblastic leukemia -ALL/MRD2014-

Treatment protocol for adult acute lymphoblastic leukemia -ALL/MRD2014- - ALL/MRD2014

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000012382
Enrollment
100
Registered
2014-01-01
Start date
2014-02-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute lymphoblastic leukemia

Interventions

Sponsors

Fukuoka Blood & Marrow Transplant Group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. acute lymphoblastic leukemia by WHO classification 2. peroxidase positive rate of the blast cell, 3% are less than it 3. The first time treatment example which does not catch chemotherapy or the radiotherapy 4. The case that is equal to or less than 65 years old more than age 15 years old 5. Performance status 0-2 6. A case without the dangerously ill internal organs disorder T.Bil equal to or less than 2.0mg/dL, Cr equal to or less than 2.0mg/dL 7. The case that an agreement by the document is provided from a patient on explanation because of final examination contents

Exclusion criteria

Exclusion criteria: 1. B-ALL(L3) of the blast cell cell surface immune globulin positive 2. A case having double cancers 3. A case with an infectious disease having difficulty with control 4. A case with a severe mental disorder 5. The pregnancy or breast-feeding woman 6. the case that the medical attendant judged to be inappropriate

Design outcomes

Primary

MeasureTime frame
3 years disease-free survival

Secondary

MeasureTime frame
5 years disease-free survival, CR rate, treatment-related toxicities

Countries

Japan

Contacts

Public ContactThe secretariat The secretariat

Fukuoka Blood & Marrow Transplant Group Head office of FBMTG

fbmtg@intmed1.med.kyushu-u.ac.jp092-642-5315

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026